MRK
27
-3
CMS
60
5
NEM
38
-4
STZ
52
2
NTRS
59
2
FLR
45
-3
LB
49
-33
PCG
93
2
KMX
61
3
SO
55
-2
HAL
53
2
FCX
61
-2
AEE
66
6
CA
25
3
RL
78
-5
EQT
59
5
IVZ
55
2
WAT
61
-3
GM
72
3
PSX
44
2
MRK
27
-3
CMS
60
5
NEM
38
-4
STZ
52
2
NTRS
59
2
FLR
45
-3
LB
49
-33
PCG
93
2
KMX
61
3
SO
55
-2
HAL
53
2
FCX
61
-2
AEE
66
6
CA
25
3
RL
78
-5
EQT
59
5
IVZ
55
2
WAT
61
-3
GM
72
3
PSX
44
2
Financhill
Back

Verrica Pharmaceuticals Quote, Financials, Valuation and Earnings

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!
Sell
25

VRCA
Verrica Pharmaceuticals

Last Price:
0.92
Seasonality Move:
34.27%

7 Day Trial

ALL ACCESS PASS

$ 7

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!

Verrica Pharmaceuticals Price Quote

$0.92
-0.04 (-4.37%)
(Updated: November 12, 2024 at 5:55 PM ET)

Verrica Pharmaceuticals Key Stats

Sell
25
Verrica Pharmaceuticals (VRCA) is a Sell
Day range:
$0.83 - $0.98
52-week range:
$0.70 - $11.41
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
4.86
P/B ratio:
0%
Volume:
1.2M
Avg. volume:
1.1M
1-year change:
-68.72%
Market cap:
$43.9M
Revenue:
$5.1M
EPS:
$-1.84

How Much Does Verrica Pharmaceuticals Make?

Is Verrica Pharmaceuticals Growing As A Company?

Data Unavailable

Verrica Pharmaceuticals Stock Price Performance

What Is Verrica Pharmaceuticals 52-Week High & Low?

Verrica Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Verrica Pharmaceuticals?

Is Verrica Pharmaceuticals Cash Flow Positive?

  • What Is VRCA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$59.4M
  • What Is Verrica Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1.7M
  • What Is Verrica Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$254K

Verrica Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    VRCA return on invested capital is -184.44%
  • What Is Verrica Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -128.78%
  • What Is VRCA Return On Equity?
    ROE is a measure of profitability and is -2619.46%

Verrica Pharmaceuticals Earnings Date & Stock Price

Verrica Pharmaceuticals Competitors

Verrica Pharmaceuticals Dividend Yield

Verrica Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -26.45%
Revenue: 0% -133.85%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 4
Sell Recommendations: 0
Price Target: 6.33
Upside from Last Price: 558.35%

Major Shareholders

  • How many VRCA shares are owned by institutional investors?
    26.7M VRCA shares are owned by institutional investors
  • How many VRCA shares are owned by insiders?
    11.7M VRCA shares are owned by insiders